About Mari Mino-Kenudson, MD

Dr. Mino-Kenudson is board-certified in anatomic pathology and signs out specimens from the gastrointestinal tract, liver, pancreas, biliary tree, lung and pleura. She also serves as a frozen section pathologist by reviewing intra-operative consultation specimens and communicating with surgeons. Her clinical interests include the classification and personalized medicine in the field of lung cancer, and malignant and premalignant lesions of the pancreas, especially intraductal papillary mucinous neoplasm (IPMN).  She is a respected teacher in anatomic pathology, having two of her mentees recently receive the Vogel Award (given to a prominent trainee) from the United States and Canadian Academy of Pathology.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Languages:

Locations

Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800

Medical Education

  • MD, Kyoto University Faculty of Medicine
  • Fellowship, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital
  • Fellowship, Tenri Hospital

American Board Certifications

  • Anatomic Pathology, American Board of Pathology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Mino-Kenudson has been conducting translational research on lung cancers in collaboration with molecular pathologists, thoracic oncologists, and basic scientists. The collaborative work has led to multiple publications including those published in Science Translational Medicine, New England Journal of Medicine, Journal of Clinical Oncology, and Clinical Cancer Research. She has also been involved in a multidisciplinary study of pancreatic intraductal papillary mucinous neoplasms (IPMNs) and has been leading clinicopathological and translational studies of pancreatic IPMN.  Her current research focus in this field is to investigate differences in molecular characteristics between different epithelial subtypes of IPMN in order to identify molecular markers to segregate IPMN lesions preoperatively that need to be resected and those that can be observed without pancreatectomy.

Publications

Reviews: Comments and Ratings